Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

Blood (2017) 130 (18): 1985–1994.

https://doi.org/10.1182/blood-2017-06-791202

Published: 2017

Includes: Supplemental data

Journal Articles

Phase III Randomized Study of Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia Comparing Standard Dose-Escalation with Progressive Dose-Escalation (JALSG CML207 study)

Koichi Miyamura, MD PhD, Shigeki Ohtake, MD PhD, Kazunori Ohnishi, MD PhD, Noriko Usui, MD PhD, Chiaki Nakaseko, MD PhD, Hiroyuki Fujita, MD PhD, Shin Fujisawa, MD PhD, Toru Sakura, MD, Hirokazu Okumura, Yoshihiro Hatta, MD PhD, Nobuhiko Emi, MD PhD, Tomoki Naoe, MD PhD

Blood (2016) 128 (22): 941.

https://doi.org/10.1182/blood.V128.22.941.941

Published: 2016

Journal Articles

Phase 1 Clinical Trial of Adoptive Immunotherapy for Acute Myelogenous Leukemia and Myelodysplastic Syndrome, Using Gene-Modified Autologous Lymphocytes Expressing WT1-Specific T-Cell Receptor

Kazushi Tanimoto, MD PhD, Hiroshi Fujiwara, MD PhD, Isao Tawara, MD PhD, Masahiro Masuya, MD PhD, Shinichi Kageyama, MD PhD, Tetsuya Nishida, MD PhD, Makoto Murata, MD PhD, Seitaro Terakura, MD PhD, Yoshiki Akatsuka, MD PhD, Hiroaki Ikeda, MD PhD, Yoshihiro Miyahara, MD PhD, Ikuei Nukaya, PhD, Kazutoh Takesako, PhD, Nobuhiko Emi, MD PhD, Naoyuki Katayama, MD PhD, Hiroshi Shiku, MD PhD, Masaki Yasukawa, MD PhD

Blood (2016) 128 (22): 1653.

https://doi.org/10.1182/blood.V128.22.1653.1653

Published: 2016

Journal Articles

Adoptive Transfer of WT1-Specific TCR Gene-Transduced Lymphocytes in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Isao Tawara, MD PhD, Masahiro Masuya, MD PhD, Shinichi Kageyama, MD PhD, Tetsuya Nishida, MD PhD, Seitaro Terakura, MD PhD, Makoto Murata, MD PhD, Hiroshi Fujiwara, MD PhD, Yoshiki Akatsuka, MD PhD, Hiroaki Ikeda, MD PhD, Yoshihiro Miyahara, MD PhD, Daisuke Tomura, PhD, Ikuei Nukaya, PhD, Kazutoh Takesako, PhD, Nobuhiko Emi, MDPhD, Masaki Yasukawa, MD PhD, Naoyuki Katayama, MD PhD, Hiroshi Shiku, MD PhD

Blood (2015) 126 (23): 97.

https://doi.org/10.1182/blood.V126.23.97.97

Published: 2015

Journal Articles

Elongation of MPL Transmembrane Domain Is a Novel Activating-Mutation in Essential Thrombocythemia

Yukiya Yamamoto, MD PhD, Sachiko Iba, Akihiro Abe, MD PhD, Nobuhiko Emi, MDPhD

Blood (2015) 126 (23): 1628.

https://doi.org/10.1182/blood.V126.23.1628.1628

Published: 2015

Journal Articles

A Varicella Outbreak in Diffuse Large B-Cell Lymphoma Patients Receiving Rituximab-Containing Chemotherapy

Akinao Okamoto, MD, Akihiro Abe, MD PhD, Masataka Okamoto, Yoko Inaguma, MD, Tokuda Masutaka, MDPhD, Satoko Morishima, MD, PhD, Masamitsu Yanada, Tadaharu Kanie, MDPhD, Yukiya Yamamoto, MD PhD, Shuichi Mizuta, MD PhD, Yoshiki Akatsuka, MD PhD, Tetsushi Yoshikawa, MDPhD, Nobuhiko Emi, MDPhD

Blood (2014) 124 (21): 5439.

https://doi.org/10.1182/blood.V124.21.5439.5439

Published: 2014

Journal Articles

Management of Adverse Events Associated with Dasatinib during Early Periods of Therapy in the Treatment of Chronic Myeloid Leukemia -a Clinical Report of Daria-01 Study

Shuichi Mizuta, MD, Hisashi Tsurumi, Masashi Sawa, MD PhD, Kana Matsumoto, PhD, Kotaro Miyao, MD, Takeshi Hara, MD PhD, Takeshi Takahashi, MD PhD, Reona Sakemura, MD, Akio Kohno, MD PhD, Mari Oba, Satoshi Morita, PhD, Junichi Sakamoto, MDPhD, Nobuhiko Emi, MDPhD

Blood (2014) 124 (21): 4537.

https://doi.org/10.1182/blood.V124.21.4537.4537

Published: 2014

Journal Articles

Prognostic Impact of Chromosomal Variation in Patients with Acute Promyelocytic Leukemia (APL); Analysis of 775 Cases Enrolled in the Japan Adult Leukemia Study Group APL Studies

Blood (2014) 124 (21): 2329.

https://doi.org/10.1182/blood.V124.21.2329.2329

Published: 2014

Journal Articles

Construction and Molecular Characterization Of a T-Cell Receptor-Like Antibody and CAR-T Cells Specific For Minor Histocompatibility Antigen HA-1H

Yoko Inaguma, MD, Yasushi Akahori, PhD, Yoshiki Akatsuka, MD, PhD, Yuko Murayama, Keiko Shiraishi, Sachiko Tsuzuki-Iba, Akemi Endoh, Juri Tsujikawa, Ayako Demachi-Okamura, PhD, Kaho Hiramatsu, Hiroh Saji, PhD, Yukiya Yamamoto, MD, PhD, Naoki Yamamoto, PhD, Nishimura Yasuharu, MD, PhD, Toshitada Takahashi, MD, PhD, Kiyotaka Kuzushima, MD, PhD, Nobuhiko Emi, MD, PhD

Blood (2013) 122 (21): 4490.

https://doi.org/10.1182/blood.V122.21.4490.4490

Published: 2013

Journal Articles

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

Sumiko Kobayashi, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Kiyoyuki Ogata, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kensuke Usuki, MD, PhD, Kazuma Ohyashiki, MD, PhD, Keiya Ozawa, MD, PhD, Yasushi Miyazaki, MD, PhD, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD

Blood (2013) 122 (21): 2795.

https://doi.org/10.1182/blood.V122.21.2795.2795

Published: 2013

Journal Articles

Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All- Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study

Takaaki Ono, MD, PhD, Akihiro Takeshita, MD, PhD, Katsuji Shinagawa, MD, PhD, Yuji Kishimoto, MD, PhD, Hitoshi Kiyoi, MD, PhD, Masaya Okada, MD, PhD, Takahiro Yamauchi, MD, PhD, Nobuhiko Emi, MD, PhD, Hiroyuki Fujita, MD, Mitsuhiro Matsuda, MD, PhD, Fumihiko Monma, MD, PhD, Shigeki Ohtake, MD, PhD, Chiaki Nakaseko, M.D., Ph.D., Masatomo Takahashi, MD, PhD, Yukihiko Kimura, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Norio Asou, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2013) 122 (21): 3950.

https://doi.org/10.1182/blood.V122.21.3950.3950

Published: 2013

Journal Articles

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Yasuko Hamada, MD, Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Namiko Okuyama, MD, Asaka Kondo, MD, PhD, Keiichi Moriya, MD, PhD, Kiyoyuki Ogata, MD, PhD, Keiji Kakumoto, Yoshihide Miyazaki, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2799.

https://doi.org/10.1182/blood.V122.21.2799.2799

Published: 2013

Journal Articles

Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia

Masamitsu Yanada, Motohiro Tsuzuki, Hiroyuki Fujita, Katsumichi Fujimaki, Shin Fujisawa, Kazutaka Sunami, Masafumi Taniwaki, Akira Ohwada, Kosuke Tsuboi, Akio Maeda, Akihiro Takeshita, Shigeki Ohtake, Yasushi Miyazaki, Yoshiko Atsuta, Yukio Kobayashi, Tomoki Naoe, Nobuhiko Emi

Blood (2013) 121 (16): 3095–3102.

https://doi.org/10.1182/blood-2012-11-466862

Published: 2013

Journal Articles

A Phase III Study of New Synthetic Retinoid Tamibarotene(Am80) Compared with ATRA in Maintenance Therapy for Newly Diagnosed Acute Promyelocytic Leukemia (APL): Japan Adult Leukemia Study Group (JALSG) APL204 Study

Blood (2012) 120 (21): 410.

https://doi.org/10.1182/blood.V120.21.410.410

Published: 2012

Journal Articles

BCOR as a Novel Fusion Partner of Retinoic Acid Receptor Alpha In a t(X;17)(p11;q12) Variant of Acute Promyelocytic Leukemia

Yukiya Yamamoto, Sachiko Tsuzuki, Motohiro Tsuzuki, Kousuke Handa, Yoko Inaguma, Nobuhiko Emi

Blood (2010) 116 (21): 1703.

https://doi.org/10.1182/blood.V116.21.1703.1703

Published: 2010

Journal Articles

BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia

Yukiya Yamamoto, Sachiko Tsuzuki, Motohiro Tsuzuki, Kousuke Handa, Yoko Inaguma, Nobuhiko Emi

Blood (2010) 116 (20): 4274–4283.

https://doi.org/10.1182/blood-2010-01-264432

Published: 2010

Includes: Supplemental data

Journal Articles

Serum α1-Acid Glycoprotein Level Associate with Imatinib Trough Plasma Concentration and Clinical Outcome in CML Patients Treated with Imatinib: Blood Level Testing of Imatinib in Nagoya (BINGO) Study.

Yuichi Ishikawa, MD, PhD, Hitoshi Kiyoi, MD, PhD, Keisuke Watanabe, MD, Yasuyuki Nakano, MD, PhD, Kunio Kitamura, MD, PhD, Akio Kohno, MD, PhD, Toshiya Yokozawa, MD, PhD, Isamu Sugiura, MD, PhD, Akitoshi Hanamura, MD, PhD, Hiroatsu Iida, MD, PhD, Kazuhito Yamamoto, MD, PhD, Ritsuro Suzuki, MD, PhD, Koichi Miyamura, MD, PhD, Nobuhiko Emi, MD, PhD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2009) 114 (22): 4266.

https://doi.org/10.1182/blood.V114.22.4266.4266

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) in Adults with Acute Myelogenous Leukemia (AML). Final Analysis of JALSG AML97 Study

Hisashi Sakamaki, M.D., Shuichi Miyawaki, M.D., Shigeki Ohtake, M.D., Nobuhiko Emi, M.D., Fumiharu Yagasaki, MD, Kinuko Mitani, M.D., Shin Matsuda, M.D., Yuuji Kishimoto, M.D., Yasushi Miyazaki, MD, PhD, Norio Asou, M.D., Masatomo Takahashi, M.D., Yoshiaki Ogawa, Sumihisa Honda, Ph.D., Ryuzo Ohno

Blood (2008) 112 (11): 347.

https://doi.org/10.1182/blood.V112.11.347.347

Published: 2008

Journal Articles

Clinical Characteristics and Outcomes in Patients with t(8;21) Acute Myeloid Leukemia in Japan.

Hiroto Narimatsu, MD, Toshiya Yokozawa, MD, Hiroatsu Iida, MD, Motohiro Tsuzuki, MD, Masaya Hayakawa, MD, Takaaki Takeo, MD, Masaki Iino, MD, Takuji Ichihashi, MD, Chiaki Kato, MD, Akiyo Sawamoto, MD, Hiroshi Sao, MD, Masamitsu Yanada, MD, Nobuhiko Emi, MD, Hitoshi Kiyoi, MD, Tetsushi Yamaguchi, MD, Tomoki Naoe, MD, Ritsuro Suzuki, MD, Isamu Sugiura, MD

Blood (2007) 110 (11): 4269.

https://doi.org/10.1182/blood.V110.11.4269.4269

Published: 2007

Journal Articles

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia.

Masamitsu Yanada, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Hideki Akiyama, MD, Noriko Usui, MD, Fumiharu Yagasaki, MD, Nobuhiko Emi, MD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD, Itsuro Jinnai, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2005) 106 (11): 1827.

https://doi.org/10.1182/blood.V106.11.1827.1827

Published: 2005

NARROW

Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

Phase III Randomized Study of Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia Comparing Standard Dose-Escalation with Progressive Dose-Escalation (JALSG CML207 study)

Phase 1 Clinical Trial of Adoptive Immunotherapy for Acute Myelogenous Leukemia and Myelodysplastic Syndrome, Using Gene-Modified Autologous Lymphocytes Expressing WT1-Specific T-Cell Receptor

Adoptive Transfer of WT1-Specific TCR Gene-Transduced Lymphocytes in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Elongation of MPL Transmembrane Domain Is a Novel Activating-Mutation in Essential Thrombocythemia

A Varicella Outbreak in Diffuse Large B-Cell Lymphoma Patients Receiving Rituximab-Containing Chemotherapy

Management of Adverse Events Associated with Dasatinib during Early Periods of Therapy in the Treatment of Chronic Myeloid Leukemia -a Clinical Report of Daria-01 Study

Prognostic Impact of Chromosomal Variation in Patients with Acute Promyelocytic Leukemia (APL); Analysis of 775 Cases Enrolled in the Japan Adult Leukemia Study Group APL Studies

Construction and Molecular Characterization Of a T-Cell Receptor-Like Antibody and CAR-T Cells Specific For Minor Histocompatibility Antigen HA-1H

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

Long-Term Outcome Of Acute Promyelocytic Leukemia (APL) With Lower Initial Leukocyte Counts By Using All- Trans Retinoic Acid (ATRA) Alone For Remission Induction Therapy: Japan Adult Leukemia Study Group (JALSG) APL97 Study

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia

A Phase III Study of New Synthetic Retinoid Tamibarotene(Am80) Compared with ATRA in Maintenance Therapy for Newly Diagnosed Acute Promyelocytic Leukemia (APL): Japan Adult Leukemia Study Group (JALSG) APL204 Study

BCOR as a Novel Fusion Partner of Retinoic Acid Receptor Alpha In a t(X;17)(p11;q12) Variant of Acute Promyelocytic Leukemia

BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia

Serum α1-Acid Glycoprotein Level Associate with Imatinib Trough Plasma Concentration and Clinical Outcome in CML Patients Treated with Imatinib: Blood Level Testing of Imatinib in Nagoya (BINGO) Study.

Allogeneic Stem Cell Transplantation (Allo-SCT) in Adults with Acute Myelogenous Leukemia (AML). Final Analysis of JALSG AML97 Study

Clinical Characteristics and Outcomes in Patients with t(8;21) Acute Myeloid Leukemia in Japan.

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only